Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After
Surgery (ERAS®) Society recommendations — Part II - ScienceDirect Skip to main contentSkip …

Simple Summary Cytoreductive surgery represents the cornerstone of the management of
advanced epithelial ovarian cancers (aEOC). Currently, two alternative strategies coexist …

Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) may
be used to treat peritoneal based malignancies, such as epithelial ovarian cancer (EOC) …

Objective To identify risk factors for anastomotic leakage (AL) in patients undergoing primary
advanced ovarian cancer surgery and to evaluate the prognostic implication of AL on overall …

Objective To determine pre-/intraoperative risk factors for anastomotic leak after modified
posterior pelvic exenteration (MPE) or colorectal resection in ovarian cancer and to create a …

Objective Determine whether a standardized protocol for temporary bowel diversion after
rectosigmoid resection (RSR) for cytoreduction can reduce the rate of anastomotic leak (AL) …

Objective To examine the use, as well as postoperative and long-term oncologic outcomes
of diverting loop ileostomy (DI) during primary debulking surgery (PDS) for ovarian cancer …

Background Cytoreductive surgery is currently the main treatment for advanced epithelial
ovarian cancer (OC), and several surgical maneuvers, including colorectal resection, are …

Introduction prediction and importance of severe postoperative complications after ovarian
cancer surgery is a strong issue in patient selection and evaluation. Pre-and early …

Objectives The aims of this study were to assess anastomotic leakage (AL) rate and risk
factors for AL in patients with advanced epithelial ovarian cancer (EOC) undergoing …